| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |